Hepatocellular carcinoma (HCC) remains a serious medical therapeutic challenge as
conventional curative avenues such as surgery and chemotherapy only benefit for few …

Although hepatocellular carcinoma (HCC) is associated with a poor prognosis, management
of early-stage HCC is often successful with highly efficacious treatment modalities such as …

Background Liver resection (LRE) and microwave ablation (MWA) for hepatocellular
carcinoma (HCC) have been widely compared. Aims To compare the therapeutic outcomes …

NLRC3 (NLR family caspase recruitment domain containing 3) has been reported as a
factor of inhibiting inflammatory responses. It's role in HCC (hepatocellular carcinoma) is still …

Background/aim Recent studies have suggested that periportal location of percutaneous
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is considered as one of …

Objectives To classify hepatocellular carcinoma (HCC) recurrence patterns after
radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) combined with …

Background Various ablation techniques have been successfully applied in tumor therapy
by locally destroying tumor. In the process of tumor ablation, a large number of tumor cell …

Background To compare the efficacy and safety of microwave ablation (MWA) and
radiofrequency ablation (RFA) as first-line treatments for perivascular HCC. Methods This …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Background Laparoscopic liver resection (LLR) and radiofrequency ablation (RFA)
represented potential treatments for patients with a single hepatocellular carcinoma (HCC) …